A Retrospective, Single-Center Comparative Cost Analysis of OnabotulinumtoxinA and AbobotulinumtoxinA for Cervical Dystonia Treatment

BACKGROUND: Chemodenervation with botulinum neurotoxin (BoNT) is recommended as first-line treatment for the management of cervical dystonia. The choice of BoNT for treatment is subject to the consideration of several factors, including cost. OBJECTIVE: To compare the costs incurred by patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Trosch, Richard M., Shillington, Alicia C., English, Marci L., Marchese, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397767/
https://www.ncbi.nlm.nih.gov/pubmed/26402386
http://dx.doi.org/10.18553/jmcp.2015.21.10.854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397767/
https://www.ncbi.nlm.nih.gov/pubmed/26402386
http://dx.doi.org/10.18553/jmcp.2015.21.10.854

Ejemplares similares